Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 75
Filter
1.
Am Sociol ; 51(4): 446-469, 2020.
Article in English | MEDLINE | ID: mdl-33132397

ABSTRACT

This article clarifies the relationship between individual freedom and social order by relying on Niklas Luhmann's social systems theory and thereby defines sociology's contribution to social evolution as sociological enlightenment, which seeks otherwiseness in living experience and action. For this purpose, Luhmann's theory will specifically be compared with Emile Durkheim's and Alfred Schutz's sociological theories. Durkheim, a "child of the Enlightenment," considered freedom a collective ideal of moral individualism and conceived that the rational state realizes freedom by spreading the civil-religious human ideal for modern social order. In contrast, Schutz, following Henri Bergson, who criticized rationality for spatially fixing inner time, regarded freedom as a given in the individual's underlying duration, not as a shared ideal. Yet, unlike Bergson, he continued relying on rationalism, and he thought that the sociological observer observes how something appears to people with the epoché of natural attitude, not what it objectively is. Inheriting this phenomenological subjectivism, Luhmann showed that the self-referentiality of consciousness also applies to society: A social system, which path-dependently emerges itself from a double contingency, observes the world in its own way based on its self-referentially constituted eigen-time. On account of this system closure, and contrary to Durkheim's illuminist belief, there is no controlling entity in a highly evolved society, where freedom results from the enlarged, diversified possibilities of living experience and action (contingency). Thus, sociological enlightenment doubts self-evidence so that society brackets the taken-for-granted social order or social reality and amplifies individuals' deviations to evolve toward freedom.

2.
Theory Soc ; 49(4): 597-630, 2020.
Article in English | MEDLINE | ID: mdl-32367903

ABSTRACT

When Thomas Luckmann, a pioneer of the "linguistic turn" in sociology, regarded Émile Durkheim as a source for the sociology of language, he had lifeworldly community-building in mind. However, the French sociologist himself understood language in the context of civil society-building. To Durkheim, language was a "social thing in the highest degree" that enabled general ideas and intermediated them to people. Abstract human ideals like the civil religion since the French Revolution could be shared through (a common) language. Thus, Durkheim took the exclusive use of French in the Third Republic's laic public education for granted, ignoring the patois in the country: This "child of the Enlightenment" considered French to be a universal language of Gesellschaft and, beyond ethno-communal elements, to work as a basis for the organic solidarity of French national civil society where the social division of labor was progressing. Durkheim's theory was predicated on civil-linguistic, not ethnolinguistic, nationalism.

4.
Biomed Res ; 40(1): 37-49, 2019.
Article in English | MEDLINE | ID: mdl-30787262

ABSTRACT

The tumor suppressor gene TP53 (gene) codes for a transcription factor which transactivates its target genes responsible for cell cycle arrest, DNA repair, apoptosis, and senescence. TP53 is well known to be the most frequent target of genetic mutations in nearly half of human cancers including oral squamous cell carcinoma (OSCC). Many p53 mutants including R248Q and R248W not only lose its tumor-suppressor activities, but also interfere with the functions of wild-type p53; this is so-called dominant-negative (DN) mutation. The DN p53 mutation is a predictor of poor outcome in patients with various cancers, and also a risk factor for metastatic recurrence in patients with OSCC. Recently it has been reported that DN p53 mutants acquire new oncogenic activities, which is named gain-of-function (GOF). This study aimed at determining whether R248Q and R248W were involved in OSCC cells' acquiring aggressive phenotypes, using SAS, HSC4 and Ca9-22 cell lines. First, two mutants p53, R248Q and R248W, were respectively transfected into SAS cells harboring recessive-type p53 (E336X). As a result, SAS cells expressing R248Q showed highly spreading, motile and invasive activities compared to parent or mock-transfected cells whereas those expressing R248W did not increase those activities. Secondly, in HSC4 cells harboring R248Q and Ca9-22 cells harboring R248W, expressions of the mutants p53 were inhibited by the transfection with siRNAs targeting p53. The inhibition of the mutants p53 decreased spreading, motile and invasive activities of HSC4 cells whereas it did not affect those activities of Ca9-22 cells. These findings suggest that R248Q p53 mutation, but not R248W p53 mutation, induces more motile and invasive potentials in human OSCC cells.


Subject(s)
Alleles , Amino Acid Substitution , Cell Movement/genetics , Genes, Dominant , Mutation , Tumor Suppressor Protein p53/genetics , Apoptosis/genetics , Carcinoma, Squamous Cell/genetics , Cell Adhesion/genetics , Cell Cycle/genetics , Cell Line, Tumor , Cell Proliferation/genetics , Extracellular Matrix/metabolism , Gene Expression , Gene Expression Regulation, Neoplastic , Genes, Reporter , Humans , Mouth Neoplasms/genetics , Protein Binding , RNA, Small Interfering/genetics , Response Elements , Tumor Suppressor Protein p53/metabolism
5.
Psychiatry Clin Neurosci ; 73(3): 116-125, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30499148

ABSTRACT

AIM: While emotional processing is implicated in various psychiatric illnesses, its differences among diagnoses are unclear. We compared associative learning of social values in patients with depression and schizophrenia by measuring skin conductance response to interpersonal stimuli. METHODS: We included 20 female outpatients each with depression and schizophrenia. They underwent Pavlovian conditioning experiments in response to a classical aversive sound, and an interpersonal stimulus that was designed to cause aversive social conditioning with actors' faces coupled with negative verbal messages. Multiple regression analysis was performed to examine the associations between the degree of conditioned response and the clinical characteristics of the participants. RESULTS: Conditioned responses during the acquisition phase in both conditions were higher in depression compared to schizophrenia. Patients with depression successfully showed fear conditioning in both conditions, and they exhibited slower extinction in the interpersonal condition. The conditioned response during the extinction phase showed a positive association with Emotion Regulation Questionnaire Expressive Suppression score, and a negative association with the Emotion Regulation Questionnaire Cognitive Reappraisal score and the use of antidepressants. Patients with schizophrenia did not become conditioned in either of the conditions. The Positive and Negative Syndrome Scale Negative Syndrome score was negatively associated with the degree of conditioned response during the acquisition phase in the interpersonal condition. CONCLUSION: Female patients with schizophrenia, especially those who prominently demonstrated negative symptoms, suggested their intrinsic impairments in the associative learning of social context. Antidepressants and adaptive emotional regulation strategy may enhance the extinction learning of aversive social conditioning in depression.


Subject(s)
Depression/physiopathology , Depression/psychology , Fear/physiology , Interpersonal Relations , Schizophrenia/physiopathology , Schizophrenic Psychology , Adult , Case-Control Studies , Conditioning, Classical/physiology , Female , Galvanic Skin Response/physiology , Humans , Young Adult
6.
J Nutr Sci ; 7: e18, 2018.
Article in English | MEDLINE | ID: mdl-29721316

ABSTRACT

We conducted a randomised, double-blind, placebo-controlled trial to elucidate the effects of dietary milk fat globule membrane (MFGM) on the physical performance of community-dwelling Japanese adults. For this 24-week study, 115 middle-aged subjects (range 50-70 years old) were invited, of whom 113 (seventy-two women, forty-one men) completed the trial. Participants were then divided into either the placebo control or MFGM group. Measurements of physical performance (without undertaking any mandatory exercise) examining muscle strength, agility and balance were tested every 6 weeks until 24 weeks. Analyses were performed using the intention-to-treat method for all participants. Although the effects of MFGM on muscle strength and agility were not significant, we noted that the parameter for balance (such as the ability to stand on one leg with eyes closed for longer durations) increased in the MFGM group (mean 10·1 (95 % CI 8·25, 12·4) s) compared with the placebo (mean 7·53 (95 % CI 6·11, 9·30) s) (P = 0·046). Similarly, application of the mixed-effect model for repeated measures under unstructured covariance also revealed that the effect of MFGM was significant when compared with the placebo (10·2 (95 % CI 8·33, 12·4) v. 7·61 (95 % CI 6·17, 9·30) s) (P = 0·045). In conclusion, we demonstrated that MFGM had an effect on the physical performance of community-dwelling Japanese adults despite mandatory exercise. However, studies using larger cohorts of individuals from different demographic backgrounds are required to further elucidate the mechanisms underlying these effects and to extend the application of MFGM.

7.
J Clin Psychiatry ; 78(2): e146-e151, 2017 02.
Article in English | MEDLINE | ID: mdl-28234437

ABSTRACT

OBJECTIVE: The aim of this post hoc analysis was to evaluate which specific depressive items could predict subsequent durable recovery in patients with bipolar depression. METHODS: The study population was at least 18 years old and met DSM-IV criteria for a major depressive episode associated with either bipolar I or II disorder. The data were derived from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), in which patients with bipolar depression were randomly assigned to treatment for acute depression with a mood stabilizer plus an adjunctive antidepressant drug or placebo. The primary and secondary outcomes were durable recovery (ie, 8 consecutive weeks of euthymia) and treatment-emergent affective switch (ie, transition to mania or hypomania), respectively. Binary logistic regression analysis was performed to identify specific symptoms whose improvement during the first 2 weeks predicted those outcomes; the score change of each individual symptom in the continuous symptom subscales for depression (SUM-D) from week 0 to week 2 was used as an independent variable. RESULTS: In the evaluable 188 participants who took placebo and active drugs, the improvement in loss of self-esteem (P = .037) or loss of energy (P = .040) at week 2 was significantly associated with higher chances of subsequent durable recovery. For participants taking active drugs (n = 91), solely the improvement in loss of energy at week 2 was significantly associated with subsequent durable recovery (P = .027). There was a significant association between the improvement of psychomotor retardation at week 2 and subsequent affective switch (P = .008). CONCLUSIONS: These findings imply that focusing on individual symptoms is important in bipolar depression, rather than relying solely on a summed score in rating scales. TRIAL REGISTRATION: The original STEP-BD dataset is registered on ClinicalTrials.gov (identifier: NCT00012558).


Subject(s)
Anticonvulsants/therapeutic use , Antidepressive Agents/therapeutic use , Bipolar Disorder/drug therapy , Bipolar Disorder/psychology , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/psychology , Adult , Affect/drug effects , Anticonvulsants/adverse effects , Antidepressive Agents/adverse effects , Arousal/drug effects , Double-Blind Method , Drug Therapy, Combination , Humans , Prognosis , Self Concept , Treatment Outcome
8.
Kekkaku ; 92(1): 1-3, 2017 Jan.
Article in Japanese | MEDLINE | ID: mdl-30646466

ABSTRACT

[Objective] To determine whether three sputum examinations with fluorescent staining are necessary to diag- nose tuberculosis (TB) in our hospital. [Patients] From April 2005 to December 2012, 379 TB patients were admitted and received anti-TB therapy in our hospital. [Methods] A retrospective study was conducted to assess the positivity rates of sputum smears based on three exami- nations. The positivity rate of first sputum smear and the cumulative smear-positive rates in the second and third were determined. Then, we also determined difference of positivity rates in sputum properties, sampling procedures and cavity formation. [Results] Of the 379 patients who met the screening criteria, 300 tested positive based on the first sputum smear (79.2%). The positivity rate of the first sputum smears was higher in the purulent sputum group than in the mucous sputum group (91.2% vs. 72.3%). Cavity formation, and sputum extraction procedures were not related to the positivity rate of the first sputum smears. In the mucous sputum group, the cumulative smear-positive rate in the second test significantly rose, but did not rise in the third test. [Conclusions] Three sputum smear examinations were necessary in patients who submitted mucous sputum samples. It is important to get purulent sputum.


Subject(s)
Sputum/microbiology , Tuberculosis/diagnosis , Humans , Retrospective Studies
9.
Environ Health Prev Med ; 21(6): 470-479, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27699688

ABSTRACT

OBJECTIVES: To prevent the onset of lifestyle-related diseases associated with metabolic syndrome (MetS) in Japan, research into the development of a useful screening method is strongly desired. We developed a new screening questionnaire (JAMRISC) utilizing a logistic regression model and evaluated its ability to predict the development of MetS, type 2 diabetes and other lifestyle-related diseases in Japanese populace. METHODS: JAMRISC questionnaire was sent to 1,850 individuals in Rumoi, a small city in Hokkaido. We received a total of 1,054 valid responses. To maximize the target individuals accurately diagnosed with MetS, logistic regression analysis was used to generate a unique metabolic syndrome score calculation formula as taking into consideration the clinical relevance of each question item as individual coefficients. RESULTS: The results of our comparative research utilizing both JAMRISC and Finnish Diabetes Risk Score (FINDRISC) questionnaires revealed the usefulness of JAMRISC for its ability to detect risks for MetS, pre-MetS, diabetes, and pre-diabetes. Study of disease risk detection via JAMRISC questionnaire targeting the 4283 residents of Rumoi indicated a high detection rate for pre-MetS (98.8 %), MetS (94.2 %), pre-diabetes (85.1 %) and type 2 diabetes (94.9 %). In addition, JAMRISC was useful not only as a MetS risk score test, but also as a screening tool for diagnosing insulin resistance. CONCLUSIONS: JAMRISC questionnaire is a useful instrument for the detection of early risk of not only MetS and type 2 diabetes but also insulin resistance.


Subject(s)
Diabetes Mellitus, Type 2/diagnosis , Insulin Resistance , Mass Screening/methods , Metabolic Syndrome/diagnosis , Surveys and Questionnaires/standards , Adult , Aged , Aged, 80 and over , Female , Humans , Japan , Logistic Models , Male , Mass Screening/instrumentation , Middle Aged , Risk Factors
10.
Kekkaku ; 91(4): 451-5, 2016 Apr.
Article in Japanese | MEDLINE | ID: mdl-27530017

ABSTRACT

PURPOSE: We report an outbreak of 64 cases of tuberculosis (TB) that spread in a welfare facility for elderly individuals. OBJECTIVE AND METHODS: First, 64 TB patients who had contact with the source patient were screened at our hospital. We examined the time course up to the discovery of symptoms and analyzed the results for variable numbers of tandem repeats (VNTR) and the drug susceptibility tests. Second, we performed chest computed tomography to examine lesions due to a previous TB infection. RESULT: The source patient had recurrent aspiration pneumonia. The delay in doctor consultation was considered day 0, and the delay of diagnosis was 267 days. On examining the contacts, we found that 29 patients had TB while 35 had a latent TB infection. Results of the VNTR and the drug susceptibility tests showed that all the patients who developed TB had the same pattern as that of the source patient. Chest computed tomography showed lesions due to a previous TB infection in 8 patients. CONCLUSION: Based on the results of the VNTR and drug susceptibility tests, we concluded that the outbreak was due to an exogenous infection from the same source. All 8 patients who showed lesions due to a previous TB infection were aged > 81 years, and TB in these patients was found to be due to exogenous re-infection.


Subject(s)
Disease Outbreaks , Tuberculosis, Pulmonary/transmission , Aged , Aged, 80 and over , Drug Resistance, Bacterial , Humans , Male , Nursing Homes , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/epidemiology
11.
Clin Respir J ; 10(6): 722-730, 2016 Nov.
Article in English | MEDLINE | ID: mdl-25626362

ABSTRACT

BACKGROUND AND AIMS: In interstitial pneumonia (IP), lymphocytes play an important role in lung injury and the involvement of integrinα4ß1 on leukocytes has previously been reported in animal models. Although the integrinα4ß1 expression level is known to be up-regulated by inflammatory cytokines, the involvement of interleukin (IL)-17A is unclear. The purpose of this study is to address the possible involvement of integrinα4ß1 on circulating lymphocytes and its correlation with serum IL-17A in interstitial lung diseases (ILDs). METHODS: We measured the expression levels of integrinα4ß1 on peripheral lymphocytes and the serum concentration of IL-17A and IL-23 in subjects with ILDs (n = 27; 14 males and 13 females, 66.7 ± 7.8 years old) and control subjects (n = 10; 5 males and 5 females, 66.6 ± 4.6 years old). RESULTS: Recombinant IL-17A up-regulated expression levels of integrinα4ß1 on healthy human lymphocytes in an in vitro experiment. Expression levels of integrinα4ß1 were significantly higher in those with acute hypersensitivity pneumonitis (HP) and non-specific IP (NSIP) compared with control. Serum IL-17A concentration was also significantly increased in acute HP and NSIP subjects compared with control. And IL-17A concentration positively correlated with integrinα4ß1 expression level (P < 0.05). Serum IL-23 was below the minimal detectable level in all subjects. CONCLUSIONS: These findings suggest that up-regulated levels of integrinα4ß1 on systemic lymphocytes and elevated serum IL-17A might be involved in the extravasation of lymphocytes in IP.


Subject(s)
Integrin alpha4beta1/metabolism , Interleukin-17/blood , Lung Diseases, Interstitial/immunology , Lymphocytes/immunology , Aged , Female , Human Umbilical Vein Endothelial Cells , Humans , Interleukin-23 Subunit p19/blood , Lung Diseases, Interstitial/blood , Male , Middle Aged , Up-Regulation
12.
Kekkaku ; 91(5): 515-518, 2016 May.
Article in Japanese | MEDLINE | ID: mdl-28661593

ABSTRACT

A 31-year-old woman developed a constant cough during the 8th week of pregnancy and was diagnosed with bronchial asthma. She was prescribed prednisolone and inhaled corticosteroids. At 28 weeks of pregnancy, she showed worsening weight loss, fever, night sweats, hoarseness, and coughs. At 31 weeks of pregnancy, a scatter shadow and cavitary lesions were detected on the chest radiograph. Acid- fast bacilli smear test and tuberculosis (TB) polymerase chain reaction tests yielded positive results (G-8), and she was diagnosed with TB. Contact tracing and screening indicated 3 patients with TB onset and 18 patients with latent TB infec- tion attributed to the initial patient, who infected a total of 36 people. In the present case, physicians were reluctant to order a chest radiograph for fear of harming the fetus and did not order sputum or interferon gamma release (IGRA) assay tests either. The diagnosis was delayed by 152 days, which was considered as a factor that caused the outbreak. The diag- nosis of TB in a pregnant patient may be very challenging because symptoms may initially be ascribed to the pregnan- cy, and delayed diagnosis and treatment of military TB can lead to the death of the mother and fetus. Consequently, to ensure early diagnosis and treatment, chest radiography and sputum and IGRA tests are recommended for pregnant women who have TB symptoms or are at high risk for TB.


Subject(s)
Pregnancy Complications, Infectious , Tuberculosis/epidemiology , Adult , Antitubercular Agents/therapeutic use , Disease Outbreaks , Drug Combinations , Female , Humans , Male , Middle Aged , Pregnancy , Tuberculosis/drug therapy
13.
J Psychiatr Res ; 68: 151-6, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26228414

ABSTRACT

The aim of this study is to evaluate whether an adjunct antidepressant therapy at a higher dose to a mood stabilizer would make a difference in the treatment of bipolar depression. This is a post-hoc analysis of the data from the randomized treatment for acute depression of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), in which patients with bipolar depression were randomly assigned to treatment with a mood stabilizer plus adjunctive antidepressant drugs or placebo. According to the highest dose received in the course of treatment, the subjects were divided into one of the following three groups: high-dose, low-dose and placebo groups. The primary and secondary outcomes were durable recovery (which was operationally defined as eight consecutive weeks with

Subject(s)
Antidepressive Agents, Second-Generation/administration & dosage , Antidepressive Agents, Second-Generation/pharmacology , Antimanic Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Bupropion/pharmacology , Paroxetine/pharmacology , Adult , Bupropion/administration & dosage , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Paroxetine/administration & dosage , Treatment Outcome
14.
PLoS One ; 10(5): e0125729, 2015.
Article in English | MEDLINE | ID: mdl-25978817

ABSTRACT

Psychophysiological markers have been focused to investigate the psychopathology of psychiatric disorders and personality subtypes. In order to understand neurobiological mechanisms underlying these conditions, fear-conditioning model has been widely used. However, simple aversive stimuli are too simplistic to understand mechanisms because most patients with psychiatric disorders are affected by social stressors. The objective of this study was to test the feasibility of a newly-designed conditioning experiment using a stimulus to cause interpersonal conflicts and examine associations between personality traits and response to that stimulus. Twenty-nine healthy individuals underwent the fear conditioning and extinction experiments in response to three types of stimuli: a simple aversive sound, disgusting pictures, and pictures of an actors' face with unpleasant verbal messages that were designed to cause interpersonal conflicts. Conditioned response was quantified by the skin conductance response (SCR). Correlations between the SCR changes, and personality traits measured by the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) and Revised NEO Personality Inventory were explored. The interpersonal conflict stimulus resulted in successful conditioning, which was subsequently extinguished, in a similar manner as the other two stimuli. Moreover, a greater degree of conditioned response to the interpersonal conflict stimulus correlated with a higher ZAN-BPD total score. Fear conditioning and extinction can be successfully achieved, using interpersonal conflicts as a stimulus. Given that conditioned fear caused by the interpersonal conflicts is likely associated with borderline personality traits, this paradigm could contribute to further understanding of underlying mechanisms of interpersonal fear implicated in borderline personality disorder.


Subject(s)
Conflict, Psychological , Fear/psychology , Adult , Female , Galvanic Skin Response/physiology , Humans , Interpersonal Relations , Sound
15.
J Asthma ; 52(2): 162-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25105556

ABSTRACT

BACKGROUND: Asthmatic death in the elderly is a serious problem worldwide. Differences in clinical skill between respiratory specialists (RS) and general practitioners (GP) are important in asthma control. The aim of this study was to compare asthma management between RS and GP. METHODS: A cross-sectional survey was carried out in Shimane, Japan, in February 2009 using a questionnaire about patient background, treatment, asthma control test (ACT) and adherence to treatment. We secured the cooperation of 48 clinics (39 private clinics and 9 general hospitals). Asthmatics were divided into the elderly and young groups, and also into the RS and GP groups. RESULTS: Clinical data of 779 patients were available for analysis. Elderly patients constituted 464 (RS group: 192, GP group: 272), while those of the young group were 315 (RS group: 207, GP group: 108). RS prescribed inhaled corticosteroids (ICSs) to their elderly and young patients more than GP. The total ACT score was higher in young RS group than in young GP group, but no such difference was noted in the elderly. Despite more asthma-related symptoms, the ACT showed that elderly GP asthmatics used fewer rescue inhalers than elderly RS. Self-assessment was higher in elderly GP than elderly RS asthmatics. Adherence to therapy was better in elderly patients than young patients. CONCLUSIONS: Elderly asthmatics treated by GPs underestimated the severity of their asthma and asthmatics seen by GPs were undertreated. The results stress the need to engage patients in educational activities, to adhere to guidelines, and to improve the coordination between GP and RS.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Anti-Asthmatic Agents/administration & dosage , Asthma/drug therapy , General Practitioners , Specialization , Administration, Inhalation , Adrenal Cortex Hormones/therapeutic use , Adult , Age Factors , Aged , Aged, 80 and over , Anti-Asthmatic Agents/therapeutic use , Asthma/epidemiology , Cross-Sectional Studies , Drug Utilization/statistics & numerical data , Female , Humans , Japan , Male , Medication Adherence/statistics & numerical data , Middle Aged , Nebulizers and Vaporizers , Patient Acuity , Practice Patterns, Physicians'/statistics & numerical data , Smoking/epidemiology
17.
J Infect Chemother ; 19(5): 909-15, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23645226

ABSTRACT

Pneumonia is associated with an extremely high mortality rate in patients of late elderly age. Piperacillin/tazobactam and carbapenems are drugs of first choice for hospitalized patients with potentially resistant bacteria. We compared the efficacy and safety of piperacillin/tazobactam and biapenem. Among elderly patients with nursing- and healthcare-associated pneumonia, we extracted 53 patients treated with piperacillin/tazobactam and 53 patients treated with biapenem who were matched for sex, age, and severity of pneumonia. The average age was more than 80 years; most of the patients were middle- to oldest old in age. Although clinical efficacy was equally good, patients in the piperacillin/tazobactam group achieved significantly faster improvements on chest X-ray and body temperature on day 7. However, in the piperacillin/tazobactam group, nephrotoxicity frequently led to a need for a reduction in the dose or complete discontinuation of treatment. The average age of patients who developed significant nephrotoxicity was high, at 83.2 years. The biapenem group exhibited significantly better continuation of treatment than the piperacillin/tazobactam group. Toxicity profiles were different between the two groups. Hepatic toxicity was significantly higher in the biapenem group, whereas nephrotoxicity was significantly more common in the piperacillin/tazobactam group. Rate of decrease in bacteria was equally good between the two groups. Providing careful follow-up and conducting more detailed examinations, including studies to determine optimal dose and timing of administration, are necessary for the treatment of late elderly patients with numerous underlying diseases and potential organ dysfunctions.


Subject(s)
Cross Infection/drug therapy , Penicillanic Acid/analogs & derivatives , Pneumonia, Bacterial/drug therapy , Thienamycins/adverse effects , Thienamycins/therapeutic use , Aged , Aged, 80 and over , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Cross Infection/microbiology , Female , Hospitalization , Humans , Male , Penicillanic Acid/adverse effects , Penicillanic Acid/therapeutic use , Piperacillin/adverse effects , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Pneumonia, Bacterial/microbiology , Retrospective Studies , Sputum/microbiology
18.
Anticancer Res ; 33(1): 261-6, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23267154

ABSTRACT

AIM: We evaluated the pharmacokinetics and quality of life of elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with bi-weekly carboplatin and paclitaxel chemotherapy, and determined the maximum tolerated dose (MTD) of this treatment. PATIENTS AND METHODS: Eligible patients had histologically- or cytologically-proven inoperable NSCLC, age of 70 years or older, no prior treatment, and Eastern Cooperative Oncology Group performance status 0-2. Paclitaxel was administered in combination with carboplatin under a bi-weekly schedule. We determined the plasma concentrations of both drugs during therapy. RESULTS: The median patient age was 80 years. Using carboplatin at AUC 3, the MTD of paclitaxel was 100 mg/m(2). Both hematological and non-hematological toxicities were mostly mild and manageable. Although paclitaxel is predominantly metabolized in the liver, clearance was decreased in patients with lower estimated glomerular filtration rate. CONCLUSION: Bi-weekly treatment, as described here, is feasible for elderly patients as a conventional regimen, particularly in the outpatient setting, due to its lower toxicity.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carboplatin/administration & dosage , Carcinoma, Non-Small-Cell Lung/drug therapy , Paclitaxel/administration & dosage , Aged , Aged, 80 and over , Carboplatin/adverse effects , Carboplatin/pharmacokinetics , Carcinoma, Non-Small-Cell Lung/pathology , Female , Humans , Male , Maximum Tolerated Dose , Neoplasm Staging , Paclitaxel/adverse effects , Paclitaxel/pharmacokinetics , Quality of Life
19.
J Infect Chemother ; 19(1): 98-102, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22926665

ABSTRACT

Although biapenem is used in the treatment of pneumonia, the clinical data on elderly patients are yet insufficient. Therefore, the purpose of this study was evaluating the efficacy and safety of biapenem against pneumonia in the elderly and its pharmacokinetics. The subjects were patients 65 years of age or older with pneumonia. Biapenem (300 mg) was administered once to three times per day. For some cases, the drug concentrations in plasma were measured chronologically. The clinical efficacy was evaluated in reference to the improvement in subjective symptoms and objective opinion. The primary outcome was efficacy rate at the end of treatment. Biapenem was effective in 17 of 20 subject cases (85.0 %). Regarding safety, although 4 cases experienced hepatic dysfunction and 1 case had nausea, these effects were not severe in all cases and administration was continued. There was no deterioration of renal function associated with biapenem. In 13 cases in which the trough value of biapenem was measured, there were no unacceptable side effects and the trough values were generally low. It is believed that biapenem (300 mg once to three times a day), even when taken by elderly people, does not accumulate and that the dosage is safe and appropriate. The changes in the predicted concentrations calculated with the pharmacokinetic-pharmacodynamic (PK-PD) software, which is based on previously reported population pharmacokinetic parameters, and those in the measured concentrations approximately matched. It is useful to plan biapenem administration using the PK-PD software when performing antibiotic chemical treatment.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Anti-Bacterial Agents/therapeutic use , Pneumonia, Bacterial/drug therapy , Thienamycins/pharmacokinetics , Thienamycins/therapeutic use , Aged , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Drug Administration Schedule , Female , Humans , Kidney Function Tests , Male , Pneumonia, Bacterial/microbiology , Thienamycins/administration & dosage , Thienamycins/adverse effects , Treatment Outcome
20.
Asian Pac J Cancer Prev ; 12(4): 947-51, 2011.
Article in English | MEDLINE | ID: mdl-21790231

ABSTRACT

Phosphatase of regenerating liver (PRL) belongs to a class of the protein tyrosine phosphatase family, which is known so far to consist of 3 members, PRL-1, PRL-2, and PRL-3. The aim of this study was to uncover the role of PRL genes in development of oral malignancy. We analyzed expression levels of the 3 PRL genes in 50 human oral squamous cell carcinomas (OSCCs), 11 dysplasia and 12 normal mucosa tissues by a real-time RT-PCR method. PRL-3 but not PRL-1 or PRL-2 expressions were significantly higher in OSCC and dysplasia than in normal mucosa tissues. Additionally, PRL-3 expressions were significantly higher in OSCC tissues harboring dominant-negative p53 or recessive p53 mutation than in those harboring wild-type p53. These results suggest that PRL-3 plays a role in oral cancer development and can be useful as a marker of pre-malignant and malignant lesion of oral mucosa.


Subject(s)
Carcinoma, Squamous Cell/genetics , Gene Expression Regulation, Neoplastic , Leukoplakia/genetics , Mouth Neoplasms/genetics , Neoplasm Proteins/genetics , Protein Tyrosine Phosphatases/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Humans , Leukoplakia/metabolism , Leukoplakia/pathology , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphatic Metastasis , Mouth Mucosa/metabolism , Mouth Mucosa/pathology , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Mutation/genetics , Neoplasm Proteins/biosynthesis , Protein Tyrosine Phosphatases/biosynthesis , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...